QNRX
Quoin Pharmaceuticals
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
News
- Quoin Pharmaceuticals receives EMA Orphan Drug Designation for QRX003 to treat peeling skin syndromeOct 14, 2026
- Quoin Pharmaceuticals announces acceptance of a QRX003 paper for publication in Dermatology and TherapyOct 6, 2026
- Quoin Pharmaceuticals receives FDA Fast Track designation for QRX003 to treat peeling skin syndromeSep 22, 2026
- FDA granted Quoin Pharmaceuticals' QRX003 Rare Pediatric Disease Designation for peeling skin syndromeSep 8, 2026
- Quoin Pharmaceuticals reported positive interim data from its ongoing Phase 2/3 trial of QRX003 in Netherton syndromeAug 28, 2026